Nanobiotix (NASDAQ:NBTX) Shares Gap Up – What’s Next?

Shares of Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) gapped up prior to trading on Wednesday. The stock had previously closed at $24.14, but opened at $25.69. Nanobiotix shares last traded at $26.4850, with a volume of 4,546 shares trading hands.

Analyst Upgrades and Downgrades

NBTX has been the topic of several analyst reports. Guggenheim assumed coverage on Nanobiotix in a research note on Tuesday, September 15th. They issued a “buy” rating and a $64.00 price objective on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Nanobiotix in a research note on Thursday, October 15th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $46.67.

Nanobiotix Trading Up 10.8%

The business’s fifty day simple moving average is $34.07 and its two-hundred day simple moving average is $36.52.

Nanobiotix Company Profile

Nanobiotix is a biotechnology company developing nanoparticle-based therapies designed to improve the effectiveness of radiotherapy in cancer treatment. The company’s technology uses hafnium oxide nanoparticles that are injected directly into a tumor and activated by ionizing radiation, with the goal of increasing energy deposition within cancer cells while limiting exposure to surrounding tissue.

Nanobiotix’s lead product candidate, NBTXR3, is being evaluated in clinical studies across several cancer types, including locally advanced head and neck cancer and other solid tumors.